Postdoctoral Fellows

Junfeng received his B.Sc. in applied chemistry at Jilin University in 2008. He joined Dr. Lowry’s group as a PhD student in 2010, focusing on chemical, enzymatic and chemo-enzymatic synthesis of complex oligosaccharides as probes of glycan functions. After obtaining PhD in Feb 2016, he works as a postdoc in Dr. Lowry’s group. He is currently working on chemo-enzymatic synthesis of group B streptococcus type III (GBSIII) glycoconjugates for understanding the mechanism of glycoconjugate vaccine activation of the immune system.

Dr. Tzu-Ting Kao obtained her B.Sc. in Organic Chemistry from National Taiwan Normal University and received her Ph.D. under the supervision of Dr. Kak-Shan Shia with Dr. Chun-Cheng Lin at National Tsing Hua University as a co-advisor in 2016. Her Ph.D. research focused on the development of an efficient radical tandem cyclization and applied the strategy to synthesize three natural products: retrojusticidin B, justicidin E and helioxanth. In 2017, she joined Dr. Lowary’s group as a postdoctoral fellow. Her research focused on the synthesis of acceptor substrates for an enzyme GlfT2, which is involved in arabinogalactan biosynthesis in Mycobacterium tuberculosis.

After finishing my Doctoral Research at Prof. Anup Kumar Misra Lab, (Bose Institute, Kolkata, India) I moved to Prof. Clay S. Bennett Lab (Tufts University, Medford, MA, USA) as a Post-Doctoral Research fellow and gained lot of experience about reagent controlled deoxy sugar glycosylation. Now here, I am to explore myself more about oligosaccharide synthesis of Streptococcus suis serotype 2 CPS and its application as glycoconjugate.

Dr. Pei-Jhen Li received her B.Sc. from National Chiayi University in 2013 and obtained her Ph.D. under the supervision of Dr. Chun- Cheng Lin at National Tsing Hua University in 2019. Her Ph.D. research focused on the carbohydrate probes of lectins modification and receptor labeling studies of cell membranes. She joined Dr. Lowary’s group as a postdoctoral fellow in 2019. Her research focused on the synthesis of capsular polysaccharide (CPS)-based vaccines against Streptococcus suis serotype 2.